Literature DB >> 7724856

Epidemiology studies of synthetic vitreous fibers: methods used and current studies.

L Chiazze1, D K Watkins.   

Abstract

Epidemiologic designs (case control, cohort, and surveillance) and measures of association are discussed in the context of studies in the Synthetic Vitreous Fibers industry. Current investigations including a case control study for Owens-Corning's Newark, Ohio plant and a Corporate-wide Mortality Surveillance System are described. The importance of internal validity and the need to account for confounding are demonstrated. Estimates of the prevalence of smoking developed for the Newark plant and the U.S. population have been used to adjust a previously reported statistically significant lung cancer Standardized Mortality Ratio (SMR) for Owens-Corning's Newark plant. After adjusting for the confounding effect of cigarette smoking, the Newark SMR based on national mortality rates is reduced to a statistically insignificant 107.7, a level quite similar to that obtained using local mortality rates. While smoking does not account for all of the excess lung cancer mortality in this population compared to U.S. mortality, these investigations make it clear that plant exposures including respirable glass fibers are not responsible for the remaining excess; rather, this excess reflects the effect of some unknown set of social, demographic, or chance factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7724856

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  2 in total

1.  Mortality from nephritis and nephrosis in the fibreglass manufacturing industry.

Authors:  L Chiazze; D K Watkins; C Fryar; W Fayerweather; J R Bender; M Chiazze
Journal:  Occup Environ Med       Date:  1999-03       Impact factor: 4.402

2.  Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study.

Authors:  Michelle K McHugh; Mirtha S Lopez; Chung-Han Ho; Margaret R Spitz; Carol J Etzel; Randa A El-Zein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-29       Impact factor: 4.254

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.